{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29
  ],
  "modelUsed": "gemini-3-flash-preview",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "Axicabtagene Ciloleucel",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects receive a 3-day conditioning chemotherapy regimen (fludarabine 30 mg/m2/day and cyclophosphamide 500 mg/m2/day) followed by a single infusion of axicabtagene ciloleucel at a target dose of 2 x 10^6 anti-CD19 CAR T cells/kg."
      },
      {
        "id": "arm_2",
        "name": "Standard of Care (SOC)",
        "type": {
          "code": "Active Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Active Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects receive investigator's choice of platinum-based salvage combination chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP). Responding subjects proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT)."
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_1"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_2"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_3"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_1",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_4"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_1",
        "epochId": "epoch_5",
        "elementIds": [
          "elem_5"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_1",
        "epochId": "epoch_6",
        "elementIds": [
          "elem_6"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_7",
        "armId": "arm_1",
        "epochId": "epoch_7",
        "elementIds": [
          "elem_7"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_8",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_8"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_9",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_9"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_10",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_10"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_11",
        "armId": "arm_2",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_11"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_12",
        "armId": "arm_2",
        "epochId": "epoch_5",
        "elementIds": [
          "elem_12"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_13",
        "armId": "arm_2",
        "epochId": "epoch_6",
        "elementIds": [
          "elem_13"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_14",
        "armId": "arm_2",
        "epochId": "epoch_7",
        "elementIds": [
          "elem_14"
        ],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [],
    "studyElements": [
      {
        "id": "elem_1",
        "name": "Axicabtagene Ciloleucel - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Axicabtagene Ciloleucel during Screening"
      },
      {
        "id": "elem_2",
        "name": "Axicabtagene Ciloleucel - Randomization",
        "instanceType": "StudyElement",
        "description": "Treatment period for Axicabtagene Ciloleucel during Randomization"
      },
      {
        "id": "elem_3",
        "name": "Axicabtagene Ciloleucel - Leukapheresis",
        "instanceType": "StudyElement",
        "description": "Treatment period for Axicabtagene Ciloleucel during Leukapheresis"
      },
      {
        "id": "elem_4",
        "name": "Axicabtagene Ciloleucel - Conditioning Chemotherapy",
        "instanceType": "StudyElement",
        "description": "Treatment period for Axicabtagene Ciloleucel during Conditioning Chemotherapy"
      },
      {
        "id": "elem_5",
        "name": "Axicabtagene Ciloleucel - IP Administration",
        "instanceType": "StudyElement",
        "description": "Treatment period for Axicabtagene Ciloleucel during IP Administration"
      },
      {
        "id": "elem_6",
        "name": "Axicabtagene Ciloleucel - Post Treatment Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for Axicabtagene Ciloleucel during Post Treatment Follow-up"
      },
      {
        "id": "elem_7",
        "name": "Axicabtagene Ciloleucel - Long-term Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for Axicabtagene Ciloleucel during Long-term Follow-up"
      },
      {
        "id": "elem_8",
        "name": "Standard of Care (SOC) - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Standard of Care (SOC) during Screening"
      },
      {
        "id": "elem_9",
        "name": "Standard of Care (SOC) - Randomization",
        "instanceType": "StudyElement",
        "description": "Treatment period for Standard of Care (SOC) during Randomization"
      },
      {
        "id": "elem_10",
        "name": "Standard of Care (SOC) - Leukapheresis",
        "instanceType": "StudyElement",
        "description": "Treatment period for Standard of Care (SOC) during Leukapheresis"
      },
      {
        "id": "elem_11",
        "name": "Standard of Care (SOC) - Conditioning Chemotherapy",
        "instanceType": "StudyElement",
        "description": "Treatment period for Standard of Care (SOC) during Conditioning Chemotherapy"
      },
      {
        "id": "elem_12",
        "name": "Standard of Care (SOC) - IP Administration",
        "instanceType": "StudyElement",
        "description": "Treatment period for Standard of Care (SOC) during IP Administration"
      },
      {
        "id": "elem_13",
        "name": "Standard of Care (SOC) - Post Treatment Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for Standard of Care (SOC) during Post Treatment Follow-up"
      },
      {
        "id": "elem_14",
        "name": "Standard of Care (SOC) - Long-term Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for Standard of Care (SOC) during Long-term Follow-up"
      }
    ],
    "summary": {
      "armCount": 2,
      "cellCount": 14,
      "cohortCount": 0,
      "elementCount": 14
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Open Label",
        "codeSystem": "USDM",
        "decode": "Open Label"
      },
      "maskedRoles": [
        "Outcome Assessor"
      ],
      "randomizationType": {
        "code": "Randomized",
        "codeSystem": "USDM",
        "decode": "Randomized"
      },
      "allocationRatio": {
        "ratio": "1:1"
      },
      "stratificationFactors": [
        "Response to first-line therapy",
        "Second-line age-adjusted International Prognostic Index (IPI)"
      ],
      "controlType": {
        "code": "Active Control",
        "codeSystem": "USDM",
        "decode": "Active Control"
      },
      "armIds": [
        "arm_1",
        "arm_2"
      ],
      "therapeuticAreas": [
        "Oncology",
        "Hematology"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Treatment"
      ],
      "blinding": {
        "schema": "Open Label",
        "maskedRoles": [
          "Outcome Assessor"
        ]
      },
      "randomization": {
        "type": "Randomized",
        "allocationRatio": "1:1",
        "stratificationFactors": [
          "Response to first-line therapy",
          "Second-line age-adjusted International Prognostic Index (IPI)"
        ]
      },
      "controlType": "Active Control",
      "therapeuticAreas": [
        "Oncology",
        "Hematology"
      ]
    },
    "arms": [
      {
        "name": "Axicabtagene Ciloleucel",
        "type": "Experimental Arm",
        "description": "Subjects receive a 3-day conditioning chemotherapy regimen (fludarabine 30 mg/m2/day and cyclophosphamide 500 mg/m2/day) followed by a single infusion of axicabtagene ciloleucel at a target dose of 2 x 10^6 anti-CD19 CAR T cells/kg.",
        "isTitration": false,
        "doseEpochs": null
      },
      {
        "name": "Standard of Care (SOC)",
        "type": "Active Comparator",
        "description": "Subjects receive investigator's choice of platinum-based salvage combination chemotherapy (R-ICE, R-DHAP, R-ESHAP, or R-GDP). Responding subjects proceed to high-dose therapy (HDT) and autologous stem cell transplant (ASCT).",
        "isTitration": false,
        "doseEpochs": null
      }
    ],
    "cohorts": [],
    "epochs": [
      {
        "name": "Screening",
        "description": "Informed consent and eligibility confirmation."
      },
      {
        "name": "Randomization",
        "description": "1:1 allocation to treatment arms."
      },
      {
        "name": "Leukapheresis",
        "description": "Collection of peripheral blood mononuclear cells (Axi-cel arm) or stem cell collection (SOC arm)."
      },
      {
        "name": "Conditioning Chemotherapy",
        "description": "Lymphodepleting regimen for Axi-cel arm or salvage chemotherapy for SOC arm."
      },
      {
        "name": "IP Administration",
        "description": "Infusion of axicabtagene ciloleucel or ASCT (for SOC responders)."
      },
      {
        "name": "Post Treatment Follow-up",
        "description": "Observation and disease assessments."
      },
      {
        "name": "Long-term Follow-up",
        "description": "Monitoring for up to 15 years for Axi-cel subjects."
      }
    ]
  }
}